.jpg)
Search
- 2 days ago
- 3 min
Leading AI medical provider, Lunit, closes on pre-IPO round of $61 million
Lunit develops AI-powered diagnostic tools for cancer screening, and biomarkers that can predict patients who respond to specific therapies.
- Nov 19
- 3 min
Alpheus Medical raises $16 million for human trials of therapy for solid body cancers
The company's lead product utilizes a novel, non-invasive drug-device combination for outpatient treatment of rGBM.
- Nov 12
- 3 min
HealthSnap raises fresh capital of $5 million to scale remote patient monitoring platform
HealthSnap helps healthcare providers manage chronic conditions such as hypertension, diabetes, and heart failure.
- Nov 6
- 3 min
Preclinical Parthenon Therapeutics closes on $65 million to advance anti-cancer therapeutics
Parthenon Therapeutics is inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment (TME).
- Nov 4
- 3 min
Infusion for Health wraps up $50 million for expansion of its chronic disease management platform
In the past year, Infusion for Health has more than quadrupled the size of its business and geographic reach to more than 20 million lives.
- Nov 1
- 2 min
Korea's Exosystems raises $3.9 million to advance musculoskeletal system, AI-based digital care
Exosystems is known for its digital care solution which consists of a wearable medical device and connected user app.
- Oct 30
- 4 min
Magnus Medical raises $25 million and launches with Breakthrough Device Designation for depression
The FDA has granted Magnus Breakthrough Device Designation for its individualized, rapid-acting, non-invasive neurostimulation technology.
- Oct 23
- 3 min
Ilumivu aquires Cardiogram and obtains funding for personalized decision solutions for healthcare
Cardiogram's cardiovascular health decision support application helps users manage chronic health conditions.
- Oct 15
- 1 min
Early-stage DeepSight Technology closes on $25 million to reinvent diagnostic imaging
DeepSight Technology provides a platform to enhance non-invasive and invasive medical imaging for multiple diagnostic procedures.
- Oct 14
- 3 min
Contract Research Organization Sai Life Sciences expands capabilities and funding
Sai Life Sciences is a CRO-CDMO that enables pharma and biotech companies to accelerate the discovery and development of small molecules.
- Oct 13
- 3 min
Merck Global Health Innovation fund makes strategic investment in Octave Bioscience
Octave Bioscience was founded to deliver an end-to-end care management platform for multiple sclerosis and neurodegenertive diseases.
- Oct 10
- 2 min
GenEdit provides update on financing and research for its polymer nanoparticles
Our NanoGalaxy platform of non-viral, non-lipid polymer nanoparticles will enable opportunities to launch genetic medicines.
- Oct 9
- 2 min
Amplo Biotechnology closes on round to advance gene therapies for neuromuscular junction disorders
"We see the potential to treat many neuromuscular diseases with a single gene therapy."
- Oct 8
- 2 min
Startup Tuune wraps up $4.6 million to advance personalized birth control
Tuune intends to improve the healthcare experience for women, starting with more informed birth control choices.
- Oct 5
- 2 min
Virica Biotech closes on financing to expand its solutions for scaling of viral medicines
Most of the new treatments for fighting cancer, rare diseases, and infections are made possible because of advances in viral medicines.
- Oct 4
- 4 min
Hemanext closes another equity round to improve the quality of red blood cells
The processing and storage of blood for transfusion is fundamental to healthcare, and over 90 million units of are transfused annually.
- Oct 2
- 2 min
Biotech Medicortex Finland Oy completes pre-IPO funding to advance diagnostic tests for brain injury
The proceeds of a net half million euro from the round will advance the development of company’s lead product candidate.
- Oct 1
- 3 min
MIT biotech spinoff Kytopen raises $30 million to advance scalable technology for cell therapies
The funding will accelerate the commercialization of Kytopen’s high-throughput automated platform which links discovery to manufacturing.
- Sep 30
- 3 min
AI-driven biotech company Envisagenics closes on Series-A financing for RNA drug discovery platform
Envisagenics' R&D focuses on diseases that are caused in part by RNA splicing deregulation and have patient populations with unmet needs.
- Sep 24
- 3 min
Garuda Therapeutics raises $72 million Series A for its blood stem cell platform to cure diseases
Garuda is developing an off-the-shelf hematopoietic stem cell platform that will eliminate dependency on donor or patient cells.